Subcutaneous Drug Delivery Devices Market Is Expected to Generate Revenue Worth US$ 71 billion by 2030, Globally

The Global Subcutaneous Drug Delivery Market Share, Trends, Analysis and Forecasts, 2020-2030 provides insights on key developments, business strategies, research & development activities, supply chain analysis, competitive landscape, and market composition analysis.

The global subcutaneous drug delivery devices market was worth US$ 22.4 billion in 2019 and is expected to reach US$ 71 billion by 2030 at a CAGR 11% during 2020 and 2030.  Subcutaneous drug delivery alludes to the medication being infused in the subcutaneous layer (layer present between the skin and muscular tissue) of an individual. This sort of medication is commonly prescribed to individuals undergoing treatment for health disorders like diabetes, malignant growth of cells or tissues namely cancer or tumors, etc. Subcutaneous sort of drug delivery has embellished as a successful option to the intravenous sort of drug administration since past few years. These sorts of injections are not skin-deep when compared to those infused in the muscles straightforwardly. Subcutaneous kind of drug provision has demonstrated to be invulnerable, very much endured, viable, and is considered by medical services suppliers and patients. This essentially brings about reduction in drug providing expenditures. Rising number of degenerative illnesses among individuals along with the accessibility of self-medication devices have pushed the evolution of worldwide subcutaneous drug delivery devices market. These drug delivery gadgets allow the patient to self-medicate as per convenience, without professional medical assistance.

View This Report With Table of Contents :

Regardless of the suitability they convey to patients, there is consistently probability of dangers identified with high measurements and overdose of medication coming about into lethal ailments. This proves to be a bigger challenge for the medical services suppliers and patients also. Manufacturers of such devices are expected to invent a device that can help review the medical specialist the specific amount of medication, time and repetition of the medication precisely after the patient has taken the medication, assisting them with rest data about the patients self-medication methods and can inform them continuously.

Access The Sample Pages of This Report :

Cost Efficiency Associated with The Device

Subcutaneous drug medication has exceptionally promoted self-medication procedures not  really needing professional support. Patients experiencing diabetes for example generally inject insulin dosages on their own. Provision of self-medication with the assistance of drug delivery device has motivated the patient with reduction in the clinic and professional charges. Home care during medical treatments provide comfort to individuals and aids in convenient monitoring of their health. Self monitoring and self-medication concerned with prolonged sicknesses like coronary illness, type 1 and type2 diabetes, respiratory issues, helps in saving expenses required in professional methods for treatment of patients.

Related report :

Global Medical Thermometer Market :

Global Speech & Voice Recognition Market :

Global Wound Closure Strips Market :

COVID-19 has led to increase in home care treatments

Corona virus outbreak worldwide is a major factor affecting medication delivery market during 2020 and onwards. Especially the individuals antecedently undergoing treatments for  hypertension, type1 and type 2 diabetes, or other chronic sicknesses are been explicitly affected. Individuals with these sorts of medical problems are advised to stay home and avoid any kind of social gatherings during the current pandemic. Owing to this situation, visiting emergency clinic, health care facilities for general medication can be deadly or unsafe for these patients. This pandemic situation accordingly have flooded the interest for home medication drug delivery gadgets. Drug delivery devices self-medication capabilities helps assist individuals with providing appropriate medication themselves during deadly pandemic avoiding any casualties caused by virus infection.

Asia Pacific region holds high potential as compared to the western regions

Albeit North America holds the significant share in the worldwide subcutaneous drug delivery gadgets market, Asia Pacific indicates momentous potential for the market during the forecast time of 2020-2030. This is mostly resulting from the advancement in biomedicine, clinical appliances and medical care attentiveness among individuals to rise in recent years. As articulated by third International conference on Diabetes, Hypertension and Metabolic Condition 2019 report the existence of diabetes among the grown-ups worldwide was about 6.4% influencing around 285 million individuals in 2010. This number would increment to 439 million out of 2030. The report expressed that there would be 69% of ascend in grown-up diabetic patients in developing nations and 20% ascent in grown-up diabetic patients in developed nations.

Key decisive players are venturing to coordinate clinical gadgets with real time data monitoring feature will acquire huge interest in the market during coming years. Also, artificial intelligence collaborations with devices invented by top organizations will assist the players in extending their consumer base worldwide.

Major players active in the global subcutaneous drug delivery devices market include Gerresheimer AG, Ypsomed AG, Novo Nordisk, Becton, Dickinson and Company, PharmaJet, Inolife Sciences, Medtronic Plc, Elcam Medical Group, Insulet Corporation, West Pharmaceutical Services, Inc. and Unilife Corporation.

Buy This Report :

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details please contact our research and consulting team at

Contact Us:



Phone (USA) : +1 707 736 6633  Email address :


Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Bulletin Track journalist was involved in the writing and production of this article.